Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 70

1.

Heterogeneity among studies in rates of decline of antiretroviral therapy adherence over time: results from the multisite adherence collaboration on HIV 14 study.

Wilson IB, Bangsberg DR, Shen J, Simoni JM, Reynolds NR, Goggin K, Gross R, Arnsten JH, Remien RH, Erlen JA, Liu H; Multisite Adherence Collaboration on HIV 14 Investigators..

J Acquir Immune Defic Syndr. 2013 Dec 15;64(5):448-54. doi: 10.1097/QAI.0000000000000025.

2.

Racial/Ethnic disparities in ART adherence in the United States: findings from the MACH14 study.

Simoni JM, Huh D, Wilson IB, Shen J, Goggin K, Reynolds NR, Remien RH, Rosen MI, Bangsberg DR, Liu H.

J Acquir Immune Defic Syndr. 2012 Aug 15;60(5):466-72.

3.

Longitudinal Analysis of Adherence to First-Line Antiretroviral Therapy: Evidence of Treatment Sustainability from an Indian HIV Cohort.

Shet A, Kumarasamy N, Poongulali S, Shastri S, Kumar DS, Rewari BB, Arumugam K, Antony J, De Costa A, D'Souza G.

Curr HIV Res. 2016;14(1):71-9.

PMID:
26303008
4.

Patterns of antiretroviral therapy adherence and impact on HIV RNA among patients in North America.

Genberg BL, Wilson IB, Bangsberg DR, Arnsten J, Goggin K, Remien RH, Simoni J, Gross R, Reynolds N, Rosen M, Liu H; MACH14 Investigators..

AIDS. 2012 Jul 17;26(11):1415-23. doi: 10.1097/QAD.0b013e328354bed6.

5.

Concurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patients.

Cantudo-Cuenca MR, Jiménez-Galán R, Almeida-Gonzalez CV, Morillo-Verdugo R.

J Manag Care Spec Pharm. 2014 Aug;20(8):844-50.

6.

Adherence to antiretroviral therapy and its correlates among HIV-infected children at an HIV clinic in New Delhi.

Bhattacharya M, Dubey AP.

Ann Trop Paediatr. 2011;31(4):331-7. doi: 10.1179/1465328111Y.0000000031.

PMID:
22041467
7.
8.
9.

Novel Approaches for Visualizing and Analyzing Dose-Timing Data from Electronic Drug Monitors, or "How the 'Broken Window' Theory Pertains to ART Adherence".

Gill CJ, DeSilva MB, Hamer DH, Keyi X, Wilson IB, Sabin L.

AIDS Behav. 2015 Nov;19(11):2057-68. doi: 10.1007/s10461-015-1065-3.

10.

Adherence to highly active antiretroviral therapy in Hyderabad, India: barriers, facilitators and identification of target groups.

Dworkin MS, Douglas GW, Sabitha Rani GP, Chakraborty A.

Int J STD AIDS. 2016 Mar;27(3):186-95. doi: 10.1177/0956462415578545. Epub 2015 Mar 22.

PMID:
25801316
11.

Patterns of adherence to antiretroviral therapy and HIV drug resistance over time in the Stratall ANRS 12110/ESTHER trial in Cameroon.

Meresse M, March L, Kouanfack C, Bonono RC, Boyer S, Laborde-Balen G, Aghokeng A, Suzan-Monti M, Delaporte E, Spire B, Carrieri MP, Laurent C; Stratall ANRS 12110/ESTHER Study Group..

HIV Med. 2014 Sep;15(8):478-87. doi: 10.1111/hiv.12140. Epub 2014 Mar 3.

12.
13.

Incomplete adherence to antiretroviral therapy is associated with higher levels of residual HIV-1 viremia.

Li JZ, Gallien S, Ribaudo H, Heisey A, Bangsberg DR, Kuritzkes DR.

AIDS. 2014 Jan 14;28(2):181-6. doi: 10.1097/QAD.0000000000000123.

14.

Migration adversely affects antiretroviral adherence in a population-based cohort of HIV/AIDS patients.

Lima V, Fernandes K, Rachlis B, Druyts E, Montaner J, Hogg R.

Soc Sci Med. 2009 Mar;68(6):1044-9. doi: 10.1016/j.socscimed.2008.12.043. Epub 2009 Jan 20.

PMID:
19157668
15.

A measurement model of medication adherence to highly active antiretroviral therapy and its relation to viral load in HIV-positive adults.

Llabre MM, Weaver KE, Durán RE, Antoni MH, McPherson-Baker S, Schneiderman N.

AIDS Patient Care STDS. 2006 Oct;20(10):701-11.

PMID:
17052140
16.

Evaluation of the first year of a pilot program in community pharmacy: HIV/AIDS medication therapy management for Medi-Cal beneficiaries.

Hirsch JD, Rosenquist A, Best BM, Miller TA, Gilmer TP.

J Manag Care Pharm. 2009 Jan-Feb;15(1):32-41.

17.

Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents.

Martin S, Elliott-DeSorbo DK, Wolters PL, Toledo-Tamula MA, Roby G, Zeichner S, Wood LV.

Pediatr Infect Dis J. 2007 Jan;26(1):61-7.

PMID:
17195708
18.
19.

Longitudinal antiretroviral adherence among adolescents infected with human immunodeficiency virus.

Murphy DA, Belzer M, Durako SJ, Sarr M, Wilson CM, Muenz LR; Adolescent Medicine HIV/AIDS Research Network..

Arch Pediatr Adolesc Med. 2005 Aug;159(8):764-70.

PMID:
16061785
20.

Impact of variability in adherence to HIV antiretroviral therapy on the immunovirological response and mortality.

Boussari O, Subtil F, Genolini C, Bastard M, Iwaz J, Fonton N, Etard JF, Ecochard R; ANRS 1215 study group..

BMC Med Res Methodol. 2015 Feb 5;15:10. doi: 10.1186/1471-2288-15-10.

Supplemental Content

Support Center